DR. MICHAEL A. BENETATOS O.D.
Prescription History 1013085521
Optometrist in Haskell, NJ
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MICHAEL A. BENETATOS O.D., an active Optometrist specialist practicing in Haskell, NJ. Our medical registry currently tracks 6 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 149 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 46 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NJ PrescribersVs. NJ Avg |
|---|---|---|---|
| Latanoprost | 46 | $8.64▼ below NJ avg | ▼ Less than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 46 Medicare prescriptions for Latanoprost, about a third of the volume of the typical New Jersey prescriber of this medication (127). Medicare paid an average of $8.64 per fill, versus $24.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 56.1 30-Day Fills standardized to 30-day supplies 1,411 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 34 | $1,395.45 | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 34 Medicare prescriptions for Restasis, about half the volume of the typical New Jersey prescriber of this medication (67). Medicare paid an average of $1,395.45 per fill, versus $1,136.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 70 30-Day Fills standardized to 30-day supplies 2,100 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 25 | $62.51 | ▼ Less than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 25 Medicare prescriptions for Timolol Maleate, about a third of the volume of the typical New Jersey prescriber of this medication (66). Medicare paid an average of $62.51 per fill, versus $38.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39 30-Day Fills standardized to 30-day supplies 1,065 Days of Medication total across all patients in 2023 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 17 | $57.85▼ below NJ avg | ▼ Less than typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye. In 2023, this provider wrote 17 Medicare prescriptions for Tobramycin-Dexamethasone, about half the volume of the typical New Jersey prescriber of this medication (33). Medicare paid an average of $57.85 per fill, versus $77.21 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 17 30-Day Fills standardized to 30-day supplies 195 Days of Medication total across all patients in 2023 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $16.05 | ▼ Less than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2023, this provider wrote 14 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a third of the volume of the typical New Jersey prescriber of this medication (43). Medicare paid an average of $16.05 per fill, versus $15.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 115 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 13 | $733.00▼ below NJ avg | ▼ Less than typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 13 Medicare prescriptions for Xiidra, about a third of the volume of the typical New Jersey prescriber of this medication (36). Medicare paid an average of $733.00 per fill, versus $1,123.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NJ prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NJ average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. MICHAEL A. BENETATOS O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Haskell, NJ practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NJ prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
